Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer
Public ClinicalTrials.gov record NCT03098836. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Study of Apalutamide and Abiraterone Acetate iN ChemoTHerapy-Naïve mEn With mCRPC Stratified by Race
Study identification
- NCT ID
- NCT03098836
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Daniel George, MD
- Other
- Enrollment
- 93 participants
Conditions and interventions
Conditions
Interventions
- ARN-509 Drug
- Abiraterone Acetate Drug
- Prednisone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 9, 2017
- Primary completion
- Jul 8, 2024
- Completion
- Jul 8, 2024
- Last update posted
- Sep 11, 2025
2017 – 2024
United States locations
- U.S. sites
- 14
- U.S. states
- 6
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tulane University | New Orleans | Louisiana | 70112 | — |
| Chesapeake Urology Associates | Baltimore | Maryland | 21204 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Duke Cancer Center Cary | Cary | North Carolina | 27518 | — |
| UNC Lineberger Cancer Center | Chapel Hill | North Carolina | 27514 | — |
| Johnston Hematology and Oncology of Clayton | Clayton | North Carolina | 27520 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Maria Parham Hospital | Henderson | North Carolina | 27536 | — |
| Scotland Memorial Hospital | Laurinburg | North Carolina | 28352 | — |
| Southeastern Regional | Lumberton | North Carolina | 28358 | — |
| Johnston Memorial Hospital | Smithfield | North Carolina | 27577 | — |
| Spartanburg Regional | Spartanburg | South Carolina | 29303 | — |
| Virginia Oncology Associates | Hampton | Virginia | 29303 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03098836, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2025 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03098836 live on ClinicalTrials.gov.